Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

W. Berdel · SciRah

Researcher profile · Semantic Scholar

W. Berdel

Share profile

W. Berdel — researcher profile on SciRah

h-index: 83
Works: 780
Citations: 28K

Most-cited papers

Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
T. Herold, M. Rothenberg-Thurley, Victoria V Grunwald, Hanna Janke +18 more
2020Leukemia157 citations Open access
Semantic Scholar
CEBPA Mutations in 4708 Patients with Acute Myeloid Leukemia - Differential Impact of bZIP and TAD Mutations on Outcome.
F. Taube, J. Georgi, M. Kramer, S. Stasik +36 more
2021Blood137 citations Open access
Semantic Scholar
The beginning of the end for conventional RECIST — novel therapies require novel imaging approaches
M. Gerwing, K. Herrmann, A. Helfen, C. Schliemann +3 more
2019Nature Reviews Clinical Oncology116 citations
Semantic Scholar
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
C. Röllig, M. Kramer, C. Schliemann, J. Mikesch +38 more
2020Blood109 citations Open access
Semantic Scholar
Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts.
L. Angenendt, C. Röllig, P. Montesinos, D. Martínez-Cuadrón +41 more
2019Journal of Clinical Oncology103 citations Open access
Semantic Scholar
Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
C. Rausch, M. Rothenberg-Thurley, A. Dufour, S. Schneider +12 more
2023Leukemia101 citations Open access
Semantic Scholar
The clinical mutatome of core binding factor leukemia
Sabrina Opatz, S. Bamopoulos, K. Metzeler, T. Herold +27 more
2020Leukemia76 citations Open access
Semantic Scholar
Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer
A. Schulze, G. Evers, Andrea Kerkhoff, M. Mohr +3 more
2019Cancers69 citations Open access
Semantic Scholar
Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response
M. Scheller, A. Ludwig, Stefanie Göllner, C. Rohde +25 more
2021Nature Cancer62 citations Open access
Semantic Scholar
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
J. Eckardt, F. Stölzel, Desiree Kunadt, C. Röllig +37 more
2022Journal of Hematology & Oncology60 citations Open access
Semantic Scholar
Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia
S. Bamopoulos, A. Batcha, V. Jurinovic, M. Rothenberg-Thurley +20 more
2020Leukemia57 citations Open access
Semantic Scholar
Loss-of-function uORF mutations in human malignancies
J. Schulz, N. Mah, M. Neuenschwander, Tabea G. Kischka +13 more
2018Scientific Reports57 citations Open access
Semantic Scholar
Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial
C. Röllig, H. Serve, R. Noppeney, M. Hanoun +39 more
2021Leukemia56 citations Open access
Semantic Scholar
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning
J. Eckardt, C. Röllig, K. Metzeler, M. Kramer +29 more
2021Haematologica51 citations Open access
Semantic Scholar
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study
J. Middeke, K. Metzeler, C. Röllig, M. Kramer +42 more
2021Blood Advances48 citations Open access
Semantic Scholar
Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia: A Randomized Clinical Trial.
M. Bornhäuser, C. Schliemann, J. Schetelig, C. Röllig +25 more
2023JAMA Oncology46 citations
Semantic Scholar
EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia
S. Stasik, J. Middeke, M. Kramer, C. Röllig +32 more
2020Haematologica41 citations Open access
Semantic Scholar
Clonal heterogeneity of FLT3-ITD detected by high-throughput amplicon sequencing correlates with adverse prognosis in acute myeloid leukemia
Katrin Schranz, M. Hubmann, E. Harin, S. Vosberg +19 more
2018OncoTarget40 citations Open access
Semantic Scholar
Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome
J. Eckardt, S. Stasik, C. Röllig, T. Sauer +33 more
2023Blood Cancer Journal34 citations Open access
Semantic Scholar
Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia.
S. Stasik, J. Eckardt, M. Kramer, C. Röllig +33 more
2021Blood Advances31 citations Open access
Semantic Scholar
Targeted siRNA nanocarrier: a platform technology for cancer treatment
N. Bäumer, Jessica Tiemann, Annika Scheller, T. Meyer +18 more
2022Oncogene28 citations Open access
Semantic Scholar
Electrostatic anti-CD33-antibody–protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia
N. Bäumer, Annika Scheller, Lisa Wittmann, A. Faust +23 more
2022Journal of Hematology & Oncology23 citations Open access
Semantic Scholar
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Desiree Kunadt, S. Stasik, K. Metzeler, C. Röllig +42 more
2022Journal of Hematology & Oncology21 citations Open access
Semantic Scholar
Long‐Term Follow‐Up on Systemic Bevacizumab Treatment in Recurrent Respiratory Papillomatosis
G. Evers, C. Schliemann, A. Beule, L. Schmidt +9 more
2020The Laryngoscope21 citations Open access
Semantic Scholar
Low‐density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemia
Matthias Floeth, S. Elges, J. Gerss, C. Schwöppe +9 more
2020British Journal of Haematology21 citations Open access
Semantic Scholar
Assessing potential locations for flood-based farming using satellite imagery: a case study of Afar region, Ethiopia
M. Gumma, T. Amede, Mezegebu Getnet, B. Pinjarla +8 more
2020Renewable Agriculture and Food Systems21 citations Open access
Semantic Scholar
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study
C. Schliemann, M. Gerwing, H. Heinzow, S. Harrach +23 more
2020Cancers20 citations Open access
Semantic Scholar
The role of autologous stem cell transplantation (ASCT) in aggressive B-cell lymphomas: real-world data from a retrospective single-center analysis
R. Wullenkord, P. Berning, Anna-Lena Niemann, Klaus Wethmar +9 more
2021Annals of Hematology19 citations Open access
Semantic Scholar
Favorable radiation field decrease in gastric marginal zone lymphoma
G. Reinartz, Regina P Pyra, G. Lenz, R. Liersch +21 more
2019Strahlentherapie und Onkologie (Print)18 citations
Semantic Scholar
Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles
J. Eckardt, C. Röllig, K. Metzeler, Peter Heisig +29 more
2023Communications Medicine17 citations Open access
Semantic Scholar
UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome
J. Georgi, S. Stasik, J. Eckardt, S. Zukunft +32 more
2023Blood Cancer Journal17 citations Open access
Semantic Scholar
Dose escalation and expansion phase I studies with the tumour-targeting antibody-tumour necrosis factor fusion protein L19TNF plus doxorubicin in patients with advanced tumours, including sarcomas.
C. Schliemann, T. Hemmerle, A. Berdel, L. Angenendt +11 more
2021European Journal of Cancer17 citations
Semantic Scholar
Inotuzumab Ozogamicin Induction Followed By Standard Chemotherapy Yields High Remission Rates and Promising Survival in Older (>55 Years) Patients with De Novo B-Lymphoblastic Leukemia (GMALL-Initial1 Trial)
M. Stelljes, N. Alakel, R. Wäsch, Sebastian Scholl +17 more
2022Blood16 citations
Semantic Scholar
Facilitating livelihoods diversification through flood-based land restoration in pastoral systems of Afar, Ethiopia
T. Amede, E. van den Akker, W. Berdel, Christina E. Keller +4 more
2020Renewable Agriculture and Food Systems16 citations Open access
Semantic Scholar
Calcitonin receptor‐like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML
L. Angenendt, M. Wöste, J. Mikesch, M. Arteaga +8 more
2021Blood Advances15 citations Open access
Semantic Scholar
Blinatumomab or Inotuzumab Ozogamicin as Bridge to Allogeneic Stem Cell Transplantation for Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis.
Patrick Stelmach, Klaus Wethmar, C. Groth, Daniela V. Wenge +7 more
2020Clinical Lymphoma, Myeloma & Leukemia14 citations
Semantic Scholar
CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process
B. Altvater, S. Kailayangiri, Christian Spurny, Maike Flügge +15 more
2023Cancer Gene Therapy13 citations Open access
Semantic Scholar
Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial
C. Röllig, B. Steffen, C. Schliemann, J. Mikesch +37 more
2022Blood13 citations Open access
Semantic Scholar
Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse
A. Berdel, L. Ruhnke, L. Angenendt, M. Wermke +20 more
2022Blood Advances12 citations Open access
Semantic Scholar
Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis
F. Pastore, A. Pastore, M. Rothenberg-Thurley, K. Metzeler +11 more
2022Cancer12 citations Open access
Semantic Scholar
Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia
J. Eckardt, S. Stasik, M. Kramer, C. Röllig +35 more
2021Cancers12 citations Open access
Semantic Scholar
Tumor‐Cell‐Specific Targeting of Ibrutinib: Introducing Electrostatic Antibody‐Inhibitor Conjugates (AiCs)
A. Faust, N. Bäumer, Alina Schlütermann, Manuel Becht +9 more
2021Angewandte Chemie12 citations Open access
Semantic Scholar
Decentralised elements in clinical trials: recommendations from the European Medicines Regulatory Network
Monique Al, S. Levison, W. Berdel, Ditte Andersen
2023The Lancet11 citations Open access
Semantic Scholar
Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic Leukemia
Daniela V. Wenge, Klaus Wethmar, Corinna A. Klar, H. Kolve +15 more
2022Cancers11 citations Open access
Semantic Scholar
Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of TP53 mutations – a registry based analysis
J. Middeke, R. Teipel, C. Röllig, S. Stasik +26 more
2021Leukemia and Lymphoma11 citations
Semantic Scholar
Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma
Christine Eisfeld, Eva Esseling, R. Wullenkord, Cyrus Khandanpour +10 more
2020Annals of Hematology11 citations Open access
Semantic Scholar
Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)
T. Kessler, S. Koschmieder, C. Schliemann, M. Crysandt +14 more
2019Annals of Hematology11 citations
Semantic Scholar
Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia
Klaus Wethmar, S. Matern, Eva Esseling, L. Angenendt +12 more
2020Bone Marrow Transplantation10 citations
Semantic Scholar
Final Induction Therapy Results of an Open Label Phase II Study Using Inotuzumab Ozogamicin for Induction Therapy, Followed By a Conventional Chemotherapy Based Consolidation and Maintenance Therapy in Patients Aged 56 Years and Older with Acute B-Lymphoblastic Leukemia (INITIAL-1 trial)
M. Stelljes, N. Alakel, R. Wäsch, Sebastian Scholl +17 more
2021Blood9 citations Open access
Semantic Scholar
Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
L. Angenendt, Isabel Hilgefort, J. Mikesch, B. Schlüter +4 more
2020Annals of Hematology9 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Schliemann×33
Invite
C. Schliemann — researcher profile on SciRah
G. Lenz×20
Invite
G. Lenz — researcher profile on SciRah
C. Röllig×19
Invite
C. Röllig — researcher profile on SciRah
C. Thiede×19
Invite
C. Thiede — researcher profile on SciRah

C. Müller-Tidow

×18

Invite

C. Müller-Tidow — researcher profile on SciRah

Invite

H. Serve — researcher profile on SciRah

J. Schetelig×17

Invite

J. Schetelig — researcher profile on SciRah

Invite

J. Middeke — researcher profile on SciRah

U. Platzbecker×16

Invite

U. Platzbecker — researcher profile on SciRah

M. Bornhäuser×16

Invite

M. Bornhäuser — researcher profile on SciRah

G. Ehninger×15

Invite

G. Ehninger — researcher profile on SciRah

A. Neubauer×14

Invite

A. Neubauer — researcher profile on SciRah